Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131
- 9 September 2005
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 33 (1) , 81-86
- https://doi.org/10.1007/s00259-005-1888-7
Abstract
Purpose The purpose of this study was twofold: (1) to measure the radiation exposure to family members of out-patients with thyrotoxicosis treated with radioiodine, 131I, using the recommendations from the European Commission (EC) guidance and age-specific periods for behaviour restrictions; (2) to use the results to identify necessary restrictions to ensure recommended dose constraints. Methods The study population comprised 76 family members (46 adults and 30 children below the age of 18) of 42 patients. The patients were treated with an average activity of 417 MBq (range 260–600 MBq). They received oral and written EC recommendations about behaviour restrictions (translated into Norwegian). On the day of treatment we repeated the oral instructions to the patient and an adult family member. The time periods for restrictions were 14 days for children aged 0–10 years, 7 days for persons aged 11–59 years and 3 days for persons aged 60 years and older. Family members wore a thermoluminescent dosimeter (TLD) on each wrist day and night for 2 weeks. The doses received were adjusted to give an estimate of the expected values if the TLDs had been worn indefinitely. Results Radiation doses well below the recommended dose constraints were measured for all adult family members and children, except one 2-year-old child; in the latter case the mother probably did not comply with the instructions given. Conclusion The radiation dose to family members of thyrotoxic patients treated with up to 600 MBq of radioiodine is well below recommended dose constraints if EC instructions are given and compliance is adequate. The duration of restrictions for various age groups used in this study may be considered when establishing guidelines in Norway.Keywords
This publication has 11 references indexed in Scilit:
- Radiation ProtectionPublished by Wiley ,2003
- Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidismEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Radionuclide therapy practice and facilities in EuropeEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centres in Flanders (Belgium).European Journal of Nuclear Medicine and Molecular Imaging, 1998
- [Measurement of incorporation in family members of radioiodine therapy patients after therapy of benign thyroid diseases].1998
- Doses in family members after 131I treatmentThe Lancet, 1997
- 131I therapy for thyrotoxicosis towards 2000European Journal of Nuclear Medicine and Molecular Imaging, 1996
- Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosisNuclear Medicine Communications, 1993
- Analysis of radiation doses received by the public from 131I treatment of thyrotoxic outpatientsNuclear Medicine Communications, 1993
- Contamination of the home environment by patients treated with Iodine-131: initial results.American Journal of Public Health, 1978